The objective of this project is to optimize imaging of cancer using radiolabeled monoclonal antibody (MAB) and to understand the factors that affect tumor and normal tissue uptake of label and MAB so that effective therapy with labeled MAB can be planned. Initial studies utilized murine anti-CEA MAB for imaging colon cancer. Patients planned for diagnostic or therapeutic operative procedures have been studied with (111) In MAB preoperatively, and imaging results have been compared with operative findings and tissue analyses. A clinical role for (111) In anti-CEA MAB imaging has been documented in presurgical cancer staging of patients with known or suspected hepatic metastases. Factors related to tumor imaging include tumor size, tumor location, tumor CEA content and tumor CEA immunohistology. A problem of post-scan artifactual elevation of plasma CEA related to HAMA production has been identified. In the current application, these studies will be augmented by further studies of MAB metabolism and human immune response to MAB. In addition, patients with adenocarcinomas of the stomach, pancreas, breast and lung will be studied. Based upon results of in vitro and animal studies in our laboratory, reduction in liver uptake will be accomplished by use of human chimeric MAB, manipulation of MAB affinity and evaluation of specific antibody pretreatment (SAP). A second panel of MABs specific for TAG-72 will be studied in similar fashion and evaluated mixed with anti-CEA MAB (""""""""cocktail""""""""). By fusion of anti-CEA hybridomas with anti-TAG-72, quadromas will be produced. The resultant bispecific hybrid MABs will be tested in nude mice and evaluated in patients for tumor uptake and imaging. It is hypothesized that bispecific antibodies will have a major benefit in dealing with tumor and cellular heterogeneity. These studies are important for critical evaluation and scientific development of labeled MAB for cancer imaging and therapy. Innovative aspects of the proposal include: preoperative imaging, tissue analyses, presurgical cancer staging, manipulations for reduction of liver uptake (SAP, affinity), human chimeric antibodies and bispecific hybrid antibodies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042329-07
Application #
3183467
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1986-05-01
Project End
1995-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
City of Hope National Medical Center
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Neumaier, M; Gaida, F J; Lewis, M R et al. (1999) A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: molecular characterization and biodistributions in normal and tumor bearing mice. Anticancer Res 19:13-21
Hu, S; Shively, L; Raubitschek, A et al. (1996) Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 56:3055-61
Wu, A M; Chen, W; Raubitschek, A et al. (1996) Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 2:21-36
Beatty, J D (1992) Immunotherapy of colorectal cancer. Cancer 70:1425-33
Wilson, L A; Kuhn, J A; Corbisiero, R M et al. (1992) A technical analysis of an intraoperative radiation detection probe. Med Phys 19:1219-23
Price, T; Beatty, B G; Beatty, J D et al. (1991) Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay. Clin Chem 37:51-7
Corbisiero, R M; Yamauchi, D M; Williams, L E et al. (1991) Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis. Cancer Res 51:5704-11
Morton, B A; O'Connor-Tressel, M; Beatty, B G et al. (1988) Artifactual CEA elevation due to human anti-mouse antibodies. Arch Surg 123:1242-6
Beatty, J D; Duda, R B; Williams, L E et al. (1986) Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody. Cancer Res 46:6494-502
Beatty, B G; Paxton, R J; Sheibani, K et al. (1986) Testis imaging with 111In-labeled anticarcinoembryonic antigen monoclonal antibody: identification of carcinoembryonic antigen in normal germ cells. Cancer Res 46:6503-8